(HB) Letrozole ( Femara ) Pack 30 tabs/pack (2.5mg/tab)
- Manufacturer: Hilma Biocare
LETROZOLE (FEMARA)
Laboratory: Hilma BiocareForm: Oral
Ingredients: Letrozole
Concentration: 2.5 mg/tablet
Presentation: Box of 30 tablets
Dosage: 1-2 tablets per day, i.e., between 2.5 mg and 5 mg per day
Type: Anti-estrogen + Stimulus
Femara is a brand name for Letrozone. This oral medication was made primarily for women who have undergone menopause as it helps in killing cells responsible for hormone receptor-positive breast cancer growth. When taken, it inhibits the production aromatase and reduces the quantities of estrogen hormone produced by ovaries hence slowing down or completely stopping the development of estrogen-dependent malignant cells. In addition, Letrozole can also be used off label by encouraging ovulation among females experiencing fertility troubles which usually entails patients who are diagnosed as having polycystic ovarian syndrome (PCOS).
The standard dosage is one tablet of 2.5 milligrams taken once daily for up to several years. Possible side effects of this medicine may include hot flushes, pain in the muscles or joints (arthralgia, myalgia), weakness (fatigue), decreased bone density leading to osteoporosis, nausea, headache, hypercholesterolemia (increased levels of cholesterol in blood). Besides, Letrozole has another indication – it promotes the maturation and release of eggs from ovaries in women who have difficulties with getting pregnant—this involves its use off-label. Periodic surveillance for osteopenia and hypercholesterolaemia is advised